Supervisor View Full Details 2nd

• neuroscience and mental health

• Medicine
• Public Health

• Clinical Trials
• Health Informatics
• Neurology
• Neurophysiology

The FutureNeuro Research Centre was established in 2017 and based in the Royal College of Surgeons in Ireland (RCSI), FutureNeuro is a world leading Science Foundation Ireland (SFI) Research Centre.

We are a collaboration between academic partners (RCSI, Trinity College Dublin, Dublin City University, NUI Galway and University College Dublin.), Clinicians and Industry.

Neurological diseases pose enormous scientific and clinical challenges. For many brain diseases we either have therapy with limited efficacy or we simply have no effective treatment. There are complex factors underlying this – and progress has been made - but a starting point is our still incomplete understanding of the mechanistic basis of many brain diseases. Diagnosis is the cornerstone of clinical care as it is the primary tool for decisions on treatment, prognosis and patient management - but for many neurological diseases this remains largely reliant on clinical examination and history. The ability to rapidly and sensitively detect biomarkers of disease and disease-risk, ideally in a point-of-care setting, would transform clinical practice. At FutureNeuro, we aim to deliver these advances in understanding disease initiation and progress. With this understanding, we will develop new technologies and solutions for the treatments, diagnosis and monitoring of chronic and rare neurological diseases.

One in four people in Ireland will be directly affected by a neurological disease during their lifetime. This includes serious neurological disorders, such as Epilepsy, that affect people of all ages, through to psychiatric diseases and both common and rare neurodegenerations, including Motor Neurone Disease (MND).

Beyond the impact on patient’s lives, supporting these conditions costs the Irish Healthcare system over €3 billion per year.

FutureNeuro is initially focusing on Epilepsy and MND, but we hope to rapidly expand into other disease areas in the very near future.